PT873134E - Formulacao aquosa de libertacao prolongada compreendendo factor de libertacao da hormona do crescimento bovino - Google Patents
Formulacao aquosa de libertacao prolongada compreendendo factor de libertacao da hormona do crescimento bovinoInfo
- Publication number
- PT873134E PT873134E PT96945382T PT96945382T PT873134E PT 873134 E PT873134 E PT 873134E PT 96945382 T PT96945382 T PT 96945382T PT 96945382 T PT96945382 T PT 96945382T PT 873134 E PT873134 E PT 873134E
- Authority
- PT
- Portugal
- Prior art keywords
- liberation
- factor
- growth hormone
- compreending
- aquosa
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 241000283690 Bos taurus Species 0.000 title abstract 2
- 238000009472 formulation Methods 0.000 title abstract 2
- 230000002035 prolonged effect Effects 0.000 title abstract 2
- 229940088597 hormone Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 title 1
- 102000038461 Growth Hormone-Releasing Hormone Human genes 0.000 abstract 3
- 239000000095 Growth Hormone-Releasing Hormone Substances 0.000 abstract 3
- 101710142969 Somatoliberin Proteins 0.000 abstract 3
- 239000007788 liquid Substances 0.000 abstract 2
- 101000825768 Bos taurus Somatoliberin Proteins 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 230000000975 bioactive effect Effects 0.000 abstract 1
- 108010006025 bovine growth hormone Proteins 0.000 abstract 1
- 238000013268 sustained release Methods 0.000 abstract 1
- 239000012730 sustained-release form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/25—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US973896P | 1996-01-11 | 1996-01-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT873134E true PT873134E (pt) | 2003-08-29 |
Family
ID=21739423
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT96945382T PT873134E (pt) | 1996-01-11 | 1996-12-13 | Formulacao aquosa de libertacao prolongada compreendendo factor de libertacao da hormona do crescimento bovino |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US6150330A (pt) |
| EP (1) | EP0873134B1 (pt) |
| JP (1) | JP2000506509A (pt) |
| KR (1) | KR100445087B1 (pt) |
| CN (1) | CN1130222C (pt) |
| AT (1) | ATE238063T1 (pt) |
| CA (1) | CA2240685A1 (pt) |
| DE (1) | DE69627706T2 (pt) |
| DK (1) | DK0873134T3 (pt) |
| ES (1) | ES2197258T3 (pt) |
| HK (1) | HK1016083A1 (pt) |
| NZ (1) | NZ326953A (pt) |
| PT (1) | PT873134E (pt) |
| WO (1) | WO1997025057A1 (pt) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2240685A1 (en) * | 1996-01-11 | 1997-07-17 | Pharmacia & Upjohn Company | Aqueous prolonged release formulation |
| EA006484B1 (ru) * | 2001-02-02 | 2005-12-29 | Конджачем, Инк. | Долгоживущие производные рилизинг-фактора гормона роста |
| CN1688696A (zh) * | 2002-09-18 | 2005-10-26 | 蒙特利尔大学医疗中心 | Ghrh类似物 |
| US8871713B2 (en) | 2013-03-01 | 2014-10-28 | Theratechnologies Inc. | Formulations of growth hormone releasing factor (GRF) molecules with improved stability |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| WO2017075535A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
| MX2023006678A (es) | 2020-12-08 | 2023-08-22 | Ruminant Biotech Corp Ltd | Mejoras en los dispositivos y métodos para suministrar sustancias a los animales. |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR890002631B1 (ko) * | 1984-10-04 | 1989-07-21 | 몬산토 캄파니 | 생물학적으로 활성인 소마토트로핀을 지속적으로 유리하는 조성물 |
| US4977140A (en) * | 1985-08-23 | 1990-12-11 | Eli Lilly And Company | Injectable sustained release formulation |
| DE69014115T2 (de) * | 1989-06-16 | 1995-05-24 | Upjohn Co | Stabilisierte, starke grf-analoga. |
| US5756458A (en) * | 1989-06-16 | 1998-05-26 | Pharmacia & Upjohn Company | Stabilized potent GRF analogs |
| EP0544706A4 (en) * | 1990-06-29 | 1993-10-13 | Hoffmann-La Roche Inc. | Histidine substituted growth hormone releasing factor analogs |
| YU87892A (sh) * | 1991-10-01 | 1995-12-04 | Eli Lilly And Company Lilly Corporate Center | Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu |
| JP3756512B2 (ja) * | 1992-09-21 | 2006-03-15 | ファルマシア・アンド・アップジョン・カンパニー・エルエルシー | 徐放性タンパク質製剤 |
| ZA949350B (en) * | 1994-01-25 | 1996-05-24 | Upjohn Co | Aqueous prolonged release formulation |
| CA2240685A1 (en) * | 1996-01-11 | 1997-07-17 | Pharmacia & Upjohn Company | Aqueous prolonged release formulation |
-
1996
- 1996-12-13 CA CA002240685A patent/CA2240685A1/en not_active Abandoned
- 1996-12-13 WO PCT/US1996/019417 patent/WO1997025057A1/en active IP Right Grant
- 1996-12-13 AT AT96945382T patent/ATE238063T1/de not_active IP Right Cessation
- 1996-12-13 CN CN96198407A patent/CN1130222C/zh not_active Expired - Fee Related
- 1996-12-13 DE DE69627706T patent/DE69627706T2/de not_active Expired - Fee Related
- 1996-12-13 ES ES96945382T patent/ES2197258T3/es not_active Expired - Lifetime
- 1996-12-13 US US08/766,563 patent/US6150330A/en not_active Expired - Fee Related
- 1996-12-13 DK DK96945382T patent/DK0873134T3/da active
- 1996-12-13 PT PT96945382T patent/PT873134E/pt unknown
- 1996-12-13 KR KR10-1998-0705291A patent/KR100445087B1/ko not_active IP Right Cessation
- 1996-12-13 EP EP96945382A patent/EP0873134B1/en not_active Expired - Lifetime
- 1996-12-13 JP JP9525193A patent/JP2000506509A/ja not_active Withdrawn
- 1996-12-13 NZ NZ326953A patent/NZ326953A/en unknown
-
1999
- 1999-03-30 HK HK99101298A patent/HK1016083A1/xx not_active IP Right Cessation
-
2000
- 2000-09-01 US US09/654,156 patent/US6429195B1/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP2000506509A (ja) | 2000-05-30 |
| EP0873134B1 (en) | 2003-04-23 |
| ES2197258T3 (es) | 2004-01-01 |
| KR100445087B1 (ko) | 2004-10-15 |
| DE69627706D1 (de) | 2003-05-28 |
| WO1997025057A1 (en) | 1997-07-17 |
| DK0873134T3 (da) | 2003-08-11 |
| AU1564997A (en) | 1997-08-01 |
| DE69627706T2 (de) | 2004-02-05 |
| KR19990077154A (ko) | 1999-10-25 |
| EP0873134A1 (en) | 1998-10-28 |
| CA2240685A1 (en) | 1997-07-17 |
| US6150330A (en) | 2000-11-21 |
| NZ326953A (en) | 2001-03-30 |
| ATE238063T1 (de) | 2003-05-15 |
| HK1016083A1 (en) | 1999-10-29 |
| US6429195B1 (en) | 2002-08-06 |
| AU705466B2 (en) | 1999-05-20 |
| CN1202114A (zh) | 1998-12-16 |
| CN1130222C (zh) | 2003-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2090714T3 (es) | Matriz de vidrio de carbohidrato para la liberacion prolongada de un agente terapeutico. | |
| DE69434418D1 (de) | Orale Dareichungsform | |
| ES2130622T3 (es) | Sistema para la administracion transdermica de farmacos. | |
| DE69434963D1 (de) | Selektiv auf die leber wirkende pharmazeutisch aktive substanz | |
| DK336986D0 (da) | Fremgangsmaade til fremstilling af toerre biologisk aktive rekombinante vaeksthormoner | |
| ES2114851T3 (es) | Utilizacion de composiciones de liberacion sostenida que contienen gnrh, lhrh o derivados de las mismas. | |
| PT873134E (pt) | Formulacao aquosa de libertacao prolongada compreendendo factor de libertacao da hormona do crescimento bovino | |
| ES2139881T3 (es) | Formulacion acuosa de liberacion retardada. | |
| ES2182983T3 (es) | Formulaciones para la liberacion de peptidos. | |
| GB8603964D0 (en) | Compositions | |
| GR3029319T3 (en) | Use of tri(n-butyl) phosphate at low pH in solutions of biologically active proteins for enhanced virucidal activity | |
| SE8600496D0 (sv) | Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions | |
| FR2684878B1 (fr) | Composition pharmaceutique stabilisee d'il2 humaine recombinante non glycosylee sous forme reduite et son procede de preparation. | |
| IL110888A0 (en) | Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative | |
| Lopez-Quijada | Failure of iodoacetate to protect the antigenic power of insulin from cystein inactivation | |
| Brandt Jr et al. | Effect of implantation and melengestrol acetate feeding on blood serum profiles and performance of heifers | |
| TH48412A3 (th) | องค์ประกอบสารกระตุ้นการเจริญเติบโต ที่ได้รับการปรับปรุง | |
| ES2125823A1 (es) | Metodo para inducir la lactacion en vacas lecheras secas y no gestantes. |